Skip to content
Austin Top 50
Author:
ALTERITY THERAPEUTICS LIMITED
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
March 30, 2026
Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit
March 9, 2026
←
Previous Page
1
2